Photo courtesy of Egypt's cabinet
The Diamond designation, the highest tier under the Angels Awards for the fourth quarter of 2025, places the complex among a limited number of stroke centres worldwide meeting top international benchmarks for diagnosis speed, treatment quality, and patient outcomes.
According to the GHA, the hospital treats more than 40 stroke emergencies a day and has delivered over six million medical services since it began operating.
GHA chairman Ahmed El-Sobky said the complex has recorded improvements in key clinical indicators, including an increase in arterial recanalization rates from 25 percent to 31 percent, reflecting faster intervention and improved acute stroke care.
He said the stroke unit operates alongside a 24-hour neuro-interventional catheterization service, allowing immediate treatment of cerebral haemorrhage, aneurysms, and vascular blockages. Post-stroke care is provided through 10 specialized outpatient clinics each week, offering follow-up and rehabilitation services.
Official figures show the complex has provided over 6 million services, including 850,000 emergency cases, 1.5 million outpatient visits, 3.9 million diagnostic and laboratory tests, and more than 82,000 surgical procedures since opening.
El-Sobky said the Ismailia Medical Complex is the first facility in Egypt to receive accreditation from both the General Authority for Healthcare Accreditation and Regulation (GAHAR) and the Joint Commission International (JCI). Its laboratories are ISO-certified, while its stroke unit holds direct accreditation from the World Stroke Organization.
The Angels Awards assess stroke centres worldwide based on performance indicators, including diagnosis speed, treatment effectiveness, adherence to clinical guidelines, and patient outcomes.
Diamond Status represents the highest level of recognition, awarded to facilities that demonstrate consistently strong performance across emergency response, intensive care, and post-stroke rehabilitation.
The programme, run by the World Stroke Organization in partnership with international stroke-care initiatives, evaluates centres every quarter using measurable criteria such as door-to-imaging time, door-to-needle time, use of reperfusion therapies, and compliance with evidence-based treatment pathways.
Short link: